Strategikon Pharma Announces New Software Release of Clinical Maestro - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Strategikon Pharma Announces New Software Release of Clinical Maestro

Strategikon Pharma announced a global update for its Clinical Maestro™ platform that advances capabilities for tracking out of scope services (aka change orders) and improves flexibility for service providers responding to requests for proposals (RFPs) through Clinical Maestro.

The LEAD module of Clinical Maestro focuses on Accruals and Forecasting. Within this module, providers can now add ‘out of scope’ changes related to minor tasks (in the contract or new) for the Sponsor’s review and negotiation. This functionality incorporates a comprehensive comments module, which documents and tracks this process for both Sponsors and Providers. Once approved, out of scope items are integrated into the next unit reports so that Providers can report consistently on the task, including the updated scope.

This comprehensive release offers additional features that enhance clinical study planning, budgeting and outsourcing through the Clinical Maestro platform, such as:

  • Providers can self-manage their team access to speed up RFP responses.
  • Both Sponsors and Providers can set top-level budget discounts that propagate to underlying categories, applicable to scenarios, RFPs, and bids.
  • Providers can modify and add tasks from Clinical Maestro’s bid grid on flexible bids.
  • Enhanced data visualisation tools for budgeting and service categories ease vetting during the bidding process.

“As Strategikon’s customer base expands, we are continually refining the Clinical Maestro platform for both Sponsors and Providers. We have seen increased sophistication and major improvements in our clients’ clinical business operations in just the last twelve months,” said Anca Copaescu, CEO of Strategikon Pharma.

“Clinical trials are very dynamic in nature and this is especially true for decentralised trials. Robust out of scope and change management capability is vital for both sides to be able to accurately track study budgets and progress against goals. The ability to quickly and easily generate accurate budgets and RFPs and to respond to requests helps improve the agility of both Sponsors and CROs and better their time to market.”

Please join us for a free webinar to learn more from an industry peer:

Embracing Change and Budgeting Technology during a Pandemic

15 April 2021, 12pm – 1pm EDT

CSL Behring will share their experiences on introducing and implementing study budgeting technology for their Global Clinical organisation. Learn about the challenges they faced and overcame, what could be done differently, whether it was worth it, and tips that can help your own organisation.

To join this free webinar, please send an enquiry through the above form.

More About This Company